Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R.A.D. Hull
2-Naphthalenesulphonyl L-Aspartyl-(2-Phenethyl)amide (2-Nap)-A Selective Cholecystokinin CCKA-receptor Antagonist
British Journal of Pharmacology
Pharmacology
Related publications
Fevipiprant, a Selective Prostaglandin-D2 Receptor-2 Antagonist, Inhibits Human Group-2 Innate Lymphoid Cell Aggregation and Function
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Development of a Rat Parathyroid Hormone 2 Receptor Antagonist
Peptides
Biochemistry
Endocrinology
Physiology
Cellular
Molecular Neuroscience
Mechanism of Activation of a G Protein-Coupled Receptor, the Human Cholecystokinin-2 Receptor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Selective Orexin-1 Receptor Antagonist, SB334867, Blocks 2-Dg-Induced Gastric Acid Secretion in Rats
Neuroscience Letters
Neuroscience
Selective Cyclooxygenase-2 Inhibitor Ameliorates Cholecystokinin-Octapeptide-Induced Acute Pancreatitis in Rats
World Journal of Gastroenterology
Medicine
Gastroenterology
High Tumorigenic Potential of a Constitutively Active Mutant of the Cholecystokinin 2 Receptor
Oncogene
Cancer Research
Genetics
Molecular Biology
Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 SRC Homology 2 Domain-Binding Antagonist
Cancer Research
Cancer Research
Oncology
Ranitidine, a Histamine-2 Receptor Antagonist, Ameliorates Caerulein-Induced Pancreatitis in Rats
The Showa University Journal of Medical Sciences
Effects of a Newly Developed Potent Orexin-2 Receptor-Selective Antagonist, Compound 1 M, on Sleep/Wakefulness States in Mice
Frontiers in Neuroscience
Neuroscience